Evidence map›Paper›PMID 35089917›Full record

ArticlePLoS neglected tropical diseases2022

Perceived COVID-19 vaccine effectiveness, acceptance, and drivers of vaccination decision-making among the general adult population: A global survey of 20 countries.

Roy Rillera Marzo, Absar Ahmad, Md Saiful Islam, Mohammad Yasir Essar, Petra Heidler, Isabel King, Arulmani Thiyagarajan, Kittisak Jermsittiparsert, Karnjana Songwathana, Delan Ameen Younus and 19 more

Abstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Roy Rillera MarzoDepartment of Community Medicine, International Medical School, Management and Science University, Shah Alam, Selangor Darul Ehsan, Malaysia.
Absar AhmadDepartment of Community Medicine, Manipal Tata Medical College, Jamshedpur, Manipal Academy of Higher Education, Manipal, India.ORCID 0000-0001-5843-4571
Md Saiful IslamDepartment of Public Health and Informatics, Jahangirnagar University, Savar, Dhaka, Bangladesh.ORCID 0000-0003-3979-2423
Mohammad Yasir EssarKabul University of Medical Sciences, Kabul, Afghanistan.
Petra HeidlerDepartment of Health Sciences, St. Pölten University of Applied Sciences, St. Pölten, Austria.ORCID 0000-0003-4979-1838
Isabel KingUniversity of the Sunshine Coast, School of Health and Behavioural Sciences, Maroochydore, Australia.
Arulmani ThiyagarajanDepartment of Clinical Epidemiology, Leibniz Institute for Prevention Research and Epidemiology-BIPS, Bremen, Germany.ORCID 0000-0002-0413-1599
Kittisak JermsittiparsertCollege of Innovative Business and Accountancy, Dhurakij Pundit University, Bangkok, Thailand.ORCID 0000-0003-3245-8705
Karnjana SongwathanaFaculty of Economics and Investment, Bangkok University, Bangkok, Thailand.
Delan Ameen YounusGeneral Directorate for Scientific Research Center, Salahaddin University-Erbil, Erbil, Iraq.ORCID 0000-0001-7323-5028
Radwa Abdullah El-AbasiriNuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.ORCID 0000-0002-5634-9848
Burcu Kucuk BicerFaculty of Medicine, Department of Medical Education and Informatics, Gazi University, Ankara, Turkey.ORCID 0000-0002-5615-264X
Nhat Tan PhamSchool of Business, International University, Ho Chi Minh City, Vietnam.ORCID 0000-0001-9927-2257
Titik RespatiDepartment of Public Health, Faculty of Medicine and Faculty of Graduate Studies, Universitas Islam Bandung, Bandung, Indonesia.ORCID 0000-0002-9214-660X
Susan FitriyanaFaculty of Medicine, Universitas Islam Bandung, Bandung, Indonesia.ORCID 0000-0003-2407-4576
Erwin Martinez FallerDepartment of Pharmacy, Faculty of Pharmacy, San Pedro College, Davao City, Philippines.ORCID 0000-0001-8269-7304
Aries Moralidad BaldonadoCollege of Nursing, Saint Alexius College, City of Koronadal, Philippines.ORCID 0000-0002-4160-4885
Md Arif BillahFaculty of Business, Economics and Social Development, Universiti Malaysia Terengganu, Kuala Terengganu, Malaysia.
Yadanar AungMedical Statistics Division, Department of Medical Research, Pyin Oo Lwin, Myanmar.ORCID 0000-0001-8670-5340
Shehu Muhammad HassanFaculty of Life Sciences, Ahmadu Bello University, Zaria, Nigeria.
Muhammad Mujtaba AsadEducation Department, Sukkur IBA University, Sukkur, Pakistan.
Kareem Ahmed El-FassDepartment of Pharmacy Practice, College of Clinical Pharmacy, King Faisal University, Al Hassa, Saudi Arabia.
Sudip BhattacharyaDepartment of Community Medicine, Himalayan Institute of Medical Sciences, Dehradun, India.
Sunil ShresthaSchool of Pharmacy, Monash University Malaysia, Bandar Sunway, Malaysia.
Nouran Ameen Elsayed HamzaMedical Agency for Research and Statistics, Giza, Egypt.
Pascal FriedmannLumpkin College of Business and Technology, Eastern Illinois University, Charleston, Illinois, United States of America.
Michael HeadClinical Informatics Research Unit, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.ORCID 0000-0003-1189-0531
Yulan LinDepartment of Epidemiology and Health Statistics, School of Public Health, Fujian Medical University, Fuzhou, China.ORCID 0000-0002-4208-9408
Siyan YiSaw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore, Singapore.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMass vaccination campaigns have significantly reduced the COVID-19 burden. However, vaccine hesitancy has posed significant global concerns. The purpose of this study was to determine the characteristics that influence perceptions of COVID-19 vaccine efficacy, acceptability, hesitancy and decision making to take vaccine among general adult populations in a variety of socioeconomic and cultural contexts.

methodsUsing a snowball sampling approach, we conducted an online cross-sectional study in 20 countries across four continents from February to May 2021.

resultsA total of 10,477 participants were included in the analyses with a mean age of 36±14.3 years. The findings revealed the prevalence of perceptions towards COVID-19 vaccine's effectiveness (78.8%), acceptance (81.8%), hesitancy (47.2%), and drivers of vaccination decision-making (convenience [73.3%], health providers' advice [81.8%], and costs [57.0%]). The county-wise distribution included effectiveness (67.8-95.9%; 67.8% in Egypt to 95.9% in Malaysia), acceptance (64.7-96.0%; 64.7% in Australia to 96.0% in Malaysia), hesitancy (31.5-86.0%; 31.5% in Egypt to 86.0% in Vietnam), convenience (49.7-95.7%; 49.7% in Austria to 95.7% in Malaysia), advice (66.1-97.3%; 66.1% in Austria to 97.3% in Malaysia), and costs (16.0-91.3%; 16.0% in Vietnam to 91.3% in Malaysia). In multivariable regression analysis, several socio-demographic characteristics were identified as associated factors of outcome variables including, i) vaccine effectiveness: younger age, male, urban residence, higher education, and higher income; ii) acceptance: younger age, male, urban residence, higher education, married, and higher income; and iii) hesitancy: male, higher education, employed, unmarried, and lower income. Likewise, the factors associated with vaccination decision-making including i) convenience: younger age, urban residence, higher education, married, and lower income; ii) advice: younger age, urban residence, higher education, unemployed/student, married, and medium income; and iii) costs: younger age, higher education, unemployed/student, and lower income.

conclusionsMost participants believed that vaccination would effectively control and prevent COVID-19, and they would take vaccinations upon availability. Determinant factors found in this study are critical and should be considered as essential elements in developing COVID-19 vaccination campaigns to boost vaccination uptake in the populations.

Indexed as

Global HealthAdultComputer Communication NetworksCOVID-19COVID-19 VaccinesCross-Sectional StudiesFemaleHumansMaleMiddle AgedSurveys and QuestionnairesVaccinationVaccination HesitancyYoung AdultCOVID-19 Vaccines

Identifiers

PMID35089917
PMCPMC8797205

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.